MICHELLE PINTO: Open Payments
NPI 1427888742 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 29 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $264 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $171 |
| Exact Sciences Corporation | 3 | $149 |
| Neurocrine BioSciences, Inc. | 2 | $149 |
| Eisai Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $37 |
| ABBVIE INC. | 2 | $37 |
| Renalytix AI, Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Smith+Nephew, Inc. | 1 | $21 |
Products named: REXULTI, INGREZZA, Cologuard Collection Kit, Leqembi, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, INJECTAFER, Ozempic, COLLAGENASE SANTYL.
Industry payments across FL — which companies pay providers there.
